Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Banlangen Injection is a traditional Chinese medicine (TCM) injectable product derived from the root of *Isatis indigotica* (Isatis root). Manufactured by Sichuan Sunnyhope Pharmaceutical, it is a sterile aqueous extract used for its heat-clearing, detoxifying, and blood-cooling properties according to TCM principles. The injection is primarily indicated for the treatment of viral infections, including influenza, upper respiratory tract infections, mumps, and sore throat. Its pharmacological profile is attributed to a complex mixture of bioactive compounds such as alkaloids, organic acids, and polysaccharides, which collectively exhibit broad-spectrum antiviral and anti-inflammatory activities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Banlangen Injection.